Vericel (NASDAQ:VCEL) has introduced that the U.S. FDA has authorised a supplemental Biologics License Application increasing the MACI® label to incorporate arthroscopic supply of MACI to…
Vericel (NASDAQ:VCEL) has introduced that the U.S. FDA has authorized a supplemental Biologics License Application increasing the MACI® label to incorporate arthroscopic supply of MACI to…
